HALOZYME THERAPEUTICS INC

Ticker: HALO CUSIP: 40637H109 Class: EQTY

Boston Trust Walden Corp's Holding History (CIK: 0001534866)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 781,835 Value ($000) $52,617 Avg Close $67.27 Range $61.23 - $76.30

Q3 2025

Shares 833,893 Value ($000) $61,158 Avg Close $66.43 Range $51.78 - $79.50

Q2 2025

Shares 845,246 Value ($000) $43,970 Avg Close $56.90 Range $47.50 - $70.51

Q1 2025

Shares 866,872 Value ($000) $55,315 Avg Close $58.09 Range $47.52 - $66.00

Q4 2024

Shares 874,081 Value ($000) $41,790 Avg Close $51.28 Range $42.01 - $62.13

Q3 2024

Shares 682,616 Value ($000) $39,073 Avg Close $57.33 Range $50.68 - $65.53

Q2 2024

Shares 443,295 Value ($000) $23,211 Avg Close $43.86 Range $37.73 - $53.00

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	781,835	$52,617	$67.27	$61.23 - $76.30
Q3 2025	833,893	$61,158	$66.43	$51.78 - $79.50
Q2 2025	845,246	$43,970	$56.90	$47.50 - $70.51
Q1 2025	866,872	$55,315	$58.09	$47.52 - $66.00
Q4 2024	874,081	$41,790	$51.28	$42.01 - $62.13
Q3 2024	682,616	$39,073	$57.33	$50.68 - $65.53
Q2 2024	443,295	$23,211	$43.86	$37.73 - $53.00